| Missing Links?: 3 Citation Matrix | Historiographs | Glossary HistCite Guide About |
|
Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments Baggerly KA, Morris JS, Coombes KR BIOINFORMATICS 20 (5): 777-U710 MAR 22 2004 and the citing papers |
Nodes: 94,
Authors: 402,
Journals: 60,
Outer References: 2542,
Words: 382
Yearly output |
Document Type |
Language |
Institution |
Institution with Subdivision |
Country
Collection span: 2004 - 2006
| View: Overview | Sorted by year, source, volume, issue, page. |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
|---|---|---|---|---|---|
| 1 | 0 | 10 | 1 2004 BIOINFORMATICS 20 (5): 777-U710 Baggerly KA; Morris JS; Coombes KR Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments | 93 | 93 |
| 2 | 1 | 21 | 2 2004 BIOINFORMATICS 20 (17): 3128-3136 Satten GA; Datta S; Moura H; Woolfitt AR; Carvalho MD; et al. Standardization and denoising algorithms for mass spectra to classify whole-organism bacterial specimens | 1 | 3 |
| 3 | 1 | 19 | 3 2004 BMC BIOINFORMATICS 5: Art. No. 180 Jeffries NO Performance of a genetic algorithm for mass spectrometry proteomics | 0 | 2 |
| 4 | 1 | 50 | 4 2004 CANCER RESEARCH 64 (16): 5882-5890 Zhang Z; Bast RC; Yu YH; Li JN; Sokoll LJ; et al. Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer | 21 | 92 |
| 5 | 1 | 18 | 5 2004 DISEASE MARKERS 20 (6): 295-307 Liggett WS; Barker PE; Semmes OJ; Cazares LH Measurement reproducibility in the early stages of biomarker development | 1 | 3 |
| 6 | 1 | 5 | 6 2004 ENDOCRINE-RELATED CANCER 11 (4): 583-584 Baggerly KA; Edmonson SR; Morris JS; Coombes KR High-resolution serum proteomic patterns for ovarian cancer detection | 2 | 3 |
| 7 | 1 | 64 | 7 2004 EXPERT REVIEW OF PROTEOMICS 1 (1): 29-36 Boggs SE Protein profiling in respiratory disease: techniques and impact | 0 | 2 |
| 8 | 1 | 58 | 8 2004 EXPERT REVIEW OF PROTEOMICS 1 (2): 185-192 Langrea MA; Wallis BS; Gillespie JW; Gannot G; Emmert-Buck MR; et al. Novel proteomic approaches for tissue analysis | 0 | 0 |
| 9 | 1 | 8 | 9 2004 INTELLIGENT DATA ENGINEERING AND AUTOMATED LEARNING IDEAL 2004, PROCEEDINGS 3177: 46-51 Luo ZY; Bellotti T; Gammerman A Qualified predictions for proteomics pattern diagnostics with confidence machines | 0 | 1 |
| 10 | 1 | 74 | 10 2004 JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 15 (7): 1677-1689 Hewitt SM; Dear J; Star RA Discovery of protein biomarkers for renal diseases | 0 | 18 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 11 | 1 | 110 | 11 2004 LABORATORY INVESTIGATION 84 (10): 1227-1244 Lim MS; Elenitoba-Johnson KSJ Proteomics in pathology research | 0 | 6 |
| 12 | 1 | 5 | 12 2004 LANCET 364 (9434): 577-578 Rockhill B Importance of disclosure of patent applications | 0 | 0 |
| 13 | 1 | 5 | 13 2004 NATURE 429 (6991): 496-497 Check E Proteomics and cancer - Running before we can walk? | 14 | 29 |
| 14 | 1 | 79 | 14 2004 NATURE REVIEWS MOLECULAR CELL BIOLOGY 5 (9): 699-711 Steen H; Mann M The ABC's (and XYZ's) of peptide sequencing | 1 | 44 |
| 15 | 1 | 24 | 15 2004 PROTEOMICS 4 (8): 2357-2360 Petricoin EF; Fishman DA; Conrads TP; Veenstra TD; Liotta LA Lessons from Kitty Hawk: From feasibility to routine clinical use for the field of proteomic pattern diagnostics | 5 | 13 |
| 16 | 2 | 8 | 16 2004 RAPID COMMUNICATIONS IN MASS SPECTROMETRY 18 (19): 2365-2366 Kolch W; Mischak H; Chalmers MJ; Pitt A; Marshall AG Clinical proteomics: a question of technology | 4 | 7 |
| 17 | 5 | 81 | 17 2005 AMERICAN JOURNAL OF PHARMACOGENOMICS 5 (5): 281-292 Rajapakse JC; Duan KB; Yeo WK Proteomic cancer classification with mass spectrometry data | 0 | 1 |
| 18 | 2 | 22 | 18 2005 ANALYTICAL AND BIOANALYTICAL CHEMISTRY 381 (1): 24-27 Flad T; Tolson J Mass spectrometry meets medical sciences: making headway in molecular disease diagnostics | 0 | 0 |
| 19 | 1 | 24 | 19 2005 ANALYTICAL CHEMISTRY 77 (2): 596-606 Colinge J; Chiappe D; Lagache S; Moniatte M; Bougueleret L Differential proteomics via probabilistic peptide identification scores | 0 | 6 |
| 20 | 3 | 197 | 20 2005 ANALYTICAL CHEMISTRY 77 (12): 3771-3787 Lambert JP; Ethier M; Smith JC; Figeys D Proteomics: from gel based to gel free | 0 | 1 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 21 | 1 | 31 | 21 2005 ANALYTICAL CHEMISTRY 77 (16): 5114-5123 West-Hielsen M; Hogdall EV; Marchiori E; Hogdall CK; Schou C; et al. Sample handling for mass spectrometric proteomic investigations of human sera | 0 | 0 |
| 22 | 4 | 41 | 22 2005 ANALYTICAL CHEMISTRY 77 (22): 7163-7171 Chalmers MJ; Mackay CL; Hendrickson CL; Wittke S; Walden M; et al. Combined top-down and bottom-up mass spectrometric approach to characterization of biomarkers for renal disease | 0 | 2 |
| 23 | 2 | 27 | 23 2005 ANALYTICAL CHEMISTRY 77 (22): 7232-7241 de Noo ME; Tollenaar RAEM; Ozalp A; Kuppen PJK; Bladergroen MR; et al. Reliability of human serum protein profiles generated with C8 magnetic beads assisted MALDI-TOF mass spectrometry | 0 | 0 |
| 24 | 1 | 35 | 24 2005 ARTHRITIS AND RHEUMATISM 52 (12): 3801-3812 de Seny D; Fillet M; Meuwis MA; Geurts P; Lutteri L; et al. Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach | 0 | 0 |
| 25 | 2 | 27 | 25 2005 BIOINFORMATICS 21 (9): 1764-1775 Morris JS; Coombes KR; Koomen J; Baggerly KA; Kobayashi R Feature extraction and quantification for mass spectrometry in biomedical applications using the mean spectrum | 0 | 3 |
| 26 | 1 | 40 | 26 2005 BIOINFORMATICS 21 (10): 2200-2209 Yu JS; Ongarello S; Fiedler R; Chen XW; Toffolo G; et al. Ovarian cancer identification based on dimensionality reduction for high-throughput mass spectrometry data | 2 | 2 |
| 27 | 2 | 14 | 27 2005 BIOINFORMATICS 21 (14): 3066-3073 Jeffries N Algorithms for alignment of mass spectrometry proteomic data | 0 | 0 |
| 28 | 4 | 26 | 28 2005 BIOINFORMATICS 21 (21): 4039-4045 Ressom HW; Varghese RS; Abdel-Hamid M; Eissa SAL; Saha D; et al. Analysis of mass spectral serum profiles for biomarker selection | 0 | 0 |
| 29 | 3 | 40 | 29 2005 BIOMETALS 18 (6): 603-613 Zhai RH; Su SH; Lu X; Liao RQ; Ge XM; et al. Proteomic profiling in the sera of workers occupationally exposed to arsenic and lead: identification of potential biomarkers | 0 | 0 |
| 30 | 1 | 118 | 30 2005 BIOSCIENCE REPORTS 25 (1-2): 71-93 Guerrera IC; Kleiner O Application of mass spectrometry in proteomics | 0 | 1 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 31 | 2 | 65 | 31 2005 BULLETIN DU CANCER 92 (9): 763-768 Solassol J; Marin P; Maudelonde T; Mange A Proteomic profiling: the potential of Seldi-Tof for the identification of new cancer biomarkers | 0 | 0 |
| 32 | 3 | 103 | 32 2005 CANCER INVESTIGATION 23 (5): 465-478 Roboz J Mass spectrometry in diagnostic oncoproteomics | 0 | 0 |
| 33 | 3 | 39 | 33 2005 CANCER RESEARCH 65 (22): 10613-10622 Honda K; Hayashida Y; Umaki T; Okusaka T; Kosuge T; et al. Possible detection of pancreatic cancer by plasma protein profiling | 0 | 0 |
| 34 | 1 | 27 | 34 2005 CHEMOMETRICS AND INTELLIGENT LABORATORY SYSTEMS 77 (1-2): 139-148 Vannucci M; Sha N; Brown PJ NIR and mass spectra classification: Bayesian methods for wavelet-based feature selection | 0 | 0 |
| 35 | 1 | 29 | 35 2005 CLINICAL CANCER RESEARCH 11 (13): 4999S-5003S Shaw AT; Kirsch DG; Jacks T Future of early detection of lung cancer: The role of mouse models | 0 | 0 |
| 36 | 2 | 27 | 36 2005 CLINICAL CANCER RESEARCH 11 (22): 8042-8047 Hayashida Y; Honda K; Osaka Y; Hara T; Umaki T; et al. Possible prediction of chemoradiosensitivity of esophageal cancer by serum protein profiling | 0 | 1 |
| 37 | 3 | 29 | 37 2005 CLINICAL CHEMISTRY 51 (1): 1-2 Coombes KR Analysis of mass spectrometry profiles of the serum proteome | 2 | 5 |
| 38 | 3 | 15 | 38 2005 CLINICAL CHEMISTRY 51 (1): 3-5 Hortin GL Can mass spectrometric protein profiling meet desired standards of clinical laboratory practice? | 5 | 7 |
| 39 | 1 | 22 | 39 2005 CLINICAL CHEMISTRY 51 (1): 65-74 Malyarenko DI; Cooke WE; Adam BL; Malik G; Chen HJ; et al. Enhancement of sensitivity and resolution of surface-enhanced, laser desorption/lonization time-of-flight mass spectrometric records for serum peptides using time-series analysis techniques | 6 | 11 |
| 40 | 2 | 39 | 40 2005 CLINICAL CHEMISTRY 51 (1): 102-112 Semmes OJ; Feng Z; Adam BL; Banez LL; Bigbee WL; et al. Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility | 16 | 36 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 41 | 6 | 16 | 41 2005 CLINICAL CHEMISTRY 51 (8): 1333-1334 Master SR Diagnostic proteomics: Back to basics? | 0 | 1 |
| 42 | 6 | 17 | 42 2005 CLINICAL CHEMISTRY 51 (8): 1525-1528 Karsan A; Eigl BJ; Flibotte S; Gelmon K; Switzer P; et al. Analytical and preanalytical biases in serum proteomic pattern analysis for breast cancer diagnosis | 2 | 5 |
| 43 | 3 | 10 | 43 2005 CLINICAL CHEMISTRY 51 (9): 1571-1572 Semmes OJ The "omics" haystack: Defining sources of sample bias in expression profiling | 0 | 0 |
| 44 | 5 | 49 | 44 2005 CLINICAL CHEMISTRY 51 (9): 1637-1649 Banks RE; Stanley AJ; Cairns DA; Barrett JH; Clarke P; et al. Influences of blood sample processing on low-molecular-weight proteome identified by surface-enhanced laser desorption/ionization mass spectrometry | 1 | 3 |
| 45 | 3 | 15 | 45 2005 CLINICAL CHEMISTRY 51 (12): 2409-2411 Findeisen P; Sismanidis D; Riedl M; Costina V; Neumaier M Preanalytical impact of sample handling on proteome profiling experiments with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry | 0 | 0 |
| 46 | 3 | 8 | 46 2005 CLINICAL CHEMISTRY AND LABORATORY MEDICINE 43 (2): 125-126 White CN; Zhang Z; Chan DW Quality control for SELDI analysis | 1 | 2 |
| 47 | 4 | 125 | 47 2005 CLINICAL SCIENCE 108 (5): 369-383 Kolch W; Mischak H; Pitt AR The molecular make-up of a tumour: proteomics in cancer research | 0 | 1 |
| 48 | 2 | 48 | 48 2005 COMPARATIVE AND FUNCTIONAL GENOMICS 6 (3): 132-137 Almeida JS; McKillen DJ; Chen YA; Gross PS; Chapman RW; et al. Design and calibration of microarrays as universal transcriptomic environmental biosensors | 0 | 0 |
| 49 | 1 | 104 | 49 2005 CURRENT MOLECULAR MEDICINE 5 (1): 39-52 Bilello JA The agony and ecstasy of "OMIC" technologies in drug development | 0 | 8 |
| 50 | 1 | 32 | 50 2005 CURRENT OPINION IN ONCOLOGY 17 (1): 44-48 Khalil IG; Hill C Systems biology for cancer | 1 | 7 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 51 | 3 | 36 | 51 2005 CURRENT OPINION IN UROLOGY 15 (3): 151-156 Banez LL; Srivastava S; Moul JW Proteomics in prostate cancer | 0 | 3 |
| 52 | 1 | 12 | 52 2005 DIAGNOSTIC CYTOPATHOLOGY 32 (4): 183-184 Zimmerman RL There's madness in the methods | 0 | 0 |
| 53 | 1 | 25 | 53 2005 DIGESTIVE SURGERY 22 (4): 276-281 de Noo ME; Liefers GJ; Tollenaar RAEM Translational research in prognostic profiling in colorectal cancer | 0 | 0 |
| 54 | 1 | 26 | 54 2005 ELECTROPHORESIS 26 (14): 2797-2808 Theodorescu D; Fliser D; Wittke S; Mischak H; Krebs R; et al. Pilot study of capillary electrophoresis coupled to mass spectrometry as a tool to define potential prostate cancer biomarkers in urine | 0 | 2 |
| 55 | 2 | 50 | 55 2005 EXPERT REVIEW OF MOLECULAR DIAGNOSTICS 5 (1): 93-100 Drake RR; Cazares LH; Semmes OJ; Wadsworth JT Serum, salivary and tissue proteomics for discovery of biomarkers for head and neck cancers | 0 | 2 |
| 56 | 3 | 16 | 56 2005 GYNECOLOGIC ONCOLOGY 99 (3): S98-S111 Lee JS; Shuhatovich O; Price R; Pikkula B; Follen M; et al. Design and preliminary analysis of a study to assess intra-device and inter-device variability of fluorescence spectroscopy instruments for detecting cervical neoplasia | 0 | 0 |
| 57 | 2 | 47 | 57 2005 HEPATOLOGY 41 (3): 634-642 Schwegler EE; Cazares L; Steel LF; Adam BL; Johnson DA; et al. SELDI-TOF MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma | 2 | 4 |
| 58 | 2 | 41 | 58 2005 IEEE TRANSACTIONS ON KNOWLEDGE AND DATA ENGINEERING 17 (8): 1127-1137 Arshadi N; Jurisica I Data mining for case-based reasoning in high-dimensional biological domains | 0 | 0 |
| 59 | 4 | 115 | 59 2005 JOURNAL OF CLINICAL ONCOLOGY 23 (20): 4524-4531 Goggins M Molecular markers of early pancreatic cancer | 0 | 4 |
| 60 | 1 | 9 | 60 2005 JOURNAL OF CLINICAL ONCOLOGY 23 (22): 4835-4837 Robbins RJ; Villanueva J; Tempst P Distilling cancer biomarkers from the serum peptidome: High technology reading of tea leaves or an insight to clinical systems biology? | 1 | 4 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 61 | 1 | 24 | 61 2005 JOURNAL OF NEUROSCIENCE RESEARCH 81 (5): 613-621 Laurent C; Levinson DF; Schwartz SA; Harrington PB; Markey SP; et al. Direct profiling of the cerebellum by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry: A methodological study in postnatal and adult mouse | 0 | 0 |
| 62 | 3 | 20 | 62 2005 JOURNAL OF PROTEOME RESEARCH 4 (4): 1060-1072 Villanueva J; Philip J; Chaparro CA; Li YB; Toledo-Crow R; et al. Correcting common errors in identifying cancer-specific serum peptide signatures | 0 | 2 |
| 63 | 3 | 80 | 63 2005 JOURNAL OF PROTEOME RESEARCH 4 (4): 1086-1097 Vitzthum F; Behrens F; Anderson NL; Shaw JH Proteomics: From basic research to diagnostic application. A review of requirements & needs | 0 | 3 |
| 64 | 5 | 92 | 64 2005 JOURNAL OF PROTEOME RESEARCH 4 (4): 1143-1154 Gillette MA; Mani DR; Carr SA Place of pattern in proteomic biomarker discovery | 0 | 1 |
| 65 | 1 | 109 | 65 2005 JOURNAL OF PROTEOME RESEARCH 4 (4): 1213-1222 Alaiya A; Al-Mohanna M; Linder S Clinical cancer proteomics: Promises and pitfalls | 0 | 1 |
| 66 | 1 | 6 | 66 2005 JOURNAL OF THE NATIONAL CANCER INSTITUTE 97 (4): 307-309 Baggerly KA; Morris JS; Edmonson SR; Coombes KR Signal in noise: Evaluating reported reproducibility of serum proteomic tests for ovarian cancer | 9 | 30 |
| 67 | 1 | 26 | 67 2005 JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION 12 (5): 349-355 Murphy VE; Johnson RF; Wang YC; Akinsanya K; Gibson PG; et al. The effect of maternal asthma on placental and cord blood protein profiles | 0 | 2 |
| 68 | 2 | 35 | 68 2005 KIDNEY INTERNATIONAL 68 (1): 193-205 Rossing K; Mischak H; Parving HH; Christensen PK; Walden M; et al. Impact of diabetic nephropathy and angiotensin II receptor blockade on urinary polypeptide patterns | 0 | 2 |
| 69 | 1 | 78 | 69 2005 MOLECULAR & CELLULAR PROTEOMICS 4 (4): 545-554 Wright ME; Han DK; Aebersold R Mass spectrometry-based expression profiling of clinical prostate cancer | 0 | 3 |
| 70 | 3 | 31 | 70 2005 MOLECULAR & CELLULAR PROTEOMICS 4 (9): 1341-1349 Dekker LJ; Boogerd W; Stockhammer G; Dalebout JC; Siccama I; et al. MALDI-TOF mass spectrometry analysis of cerebrospinal fluid tryptic peptide profiles to diagnose leptomeningeal metastases in patients with breast cancer | 0 | 0 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 71 | 2 | 66 | 71 2005 MOLECULAR AND CELLULAR ENDOCRINOLOGY 230 (1-2): 95-106 Xiao Z; Prieto D; Conrads TP; Veenstra TD; Issaq HJ Proteomic patterns: their potential for disease diagnosis | 1 | 9 |
| 72 | 2 | 34 | 72 2005 MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS 592 (1-2): 147-154 Hayes RB; Sigurdson A; Moore L; Peters U; Huang WY; et al. Methods for etiologic and early marker investigations in the PLCO trial | 0 | 1 |
| 73 | 5 | 34 | 73 2005 NATURE BIOTECHNOLOGY 23 (3): 291-292 Coombes KR; Morris JRS; Hu JH; Edmonson SR; Baggerly KA Serum proteomics profiling - a young technology begins to mature | 4 | 10 |
| 74 | 3 | 63 | 74 2005 NATURE REVIEWS CANCER 5 (2): 142-149 Ransohoff DF Opinion - Bias as a threat to the validity of cancer molecular-marker research | 5 | 22 |
| 75 | 2 | 22 | 75 2005 PATHOLOGY RESEARCH AND PRACTICE 201 (12): 763-770 Traub F; Feist H; Kreipe HH; Pich A SELDI-MS-based expression profiling of ductal invasive and lobular invasive human breast carcinomas | 0 | 0 |
| 76 | 6 | 51 | 76 2005 PHARMACOGENOMICS 6 (6): 647-653 Simpkins F; Czechowicz JA; Liotta L; Kohn EC SELDI-TOF mass spectrometry for cancer biomarker discovery and serum proteomic diagnostics | 0 | 1 |
| 77 | 2 | 61 | 77 2005 PROTEOMICS 5 (7): 1953-1966 Guo JZ; Yang ECC; DeSouza L; Diehl G; Rodrigues MJ; et al. A strategy for high-resolution protein identification in surface-enhanced laser desorption/ionization mass spectrometry: Calgranulin A and chaperonin 10 as protein markers for endometrial carcinoma | 0 | 1 |
| 78 | 1 | 35 | 78 2005 PROTEOMICS 5 (8): 2238-2246 Mitchell BL; Yasui Y; Lampe JW; Gafken PR; Lampe PD Evaluation of matrix-assisted laser desorption/ionization-time of flight mass spectrometry proteomic profiling: identification of alpha 2-HS glycoprotein B-chain as a biomarker of diet | 0 | 1 |
| 79 | 2 | 18 | 79 2005 PROTEOMICS 5 (11): 2778-2788 Carlson SM; Najmi A; Whitin JC; Cohen HJ Improving feature detection and analysis of surface-enhanced laser desorption/ionization-time of flight mass spectra | 0 | 0 |
| 80 | 2 | 25 | 80 2005 PROTEOMICS 5 (15): 4012-4024 Nelsestuen GL; Zhang Y; Martinez MB; Key NS; Jilma B; et al. Plasma protein profiling: Unique and stable features of individuals | 0 | 1 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 81 | 1 | 30 | 81 2005 PROTEOMICS 5 (16): 4107-4117 Coombes KR; Tsavachidis S; Morris JS; Baggerly KA; Hung MC; et al. Improved peak detection and quantification of mass spectrometry data acquired from surface-enhanced laser desorption and ionization by denoising spectra with the undecimated discrete wavelet transform | 0 | 0 |
| 82 | 1 | 13 | 82 2005 RAPID COMMUNICATIONS IN MASS SPECTROMETRY 19 (7): 865-870 Dekker LJ; Dalebout JC; Siccama I; Jenster G; Smitt PAS; et al. A new method to analyze matrix-assisted laser desorption/ionization time-of-flight peptide profiling mass spectra | 1 | 2 |
| 83 | 2 | 5 | 83 2005 SCIENTIST 19 (18): 20-21 Constans A Rethinking clinical proteomics | 1 | 0 |
| 84 | 2 | 32 | 84 2005 STATISTICAL SCIENCE 20 (3): 231-238 De Veaux RD; Hand DJ How to lie with bad data | 0 | 0 |
| 85 | 1 | 54 | 85 2005 SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND 3 (6): 383-390 Henderson NA; Steele RJC SELDI-TOF proteomic analysis and cancer detection | 0 | 0 |
| 86 | 2 | 36 | 86 2006 ANNALS OF HEMATOLOGY 85 (4): 205-211 Weissinger EM; Mischak H; Ganser A; Hertenstein B Value of proteomics applied to the follow-up in stem cell transplantation | 0 | 0 |
| 87 | 3 | 25 | 87 2006 BRITISH JOURNAL OF CANCER 94 (2): 287-292 Ward DG; Cheng Y; N'Kontchou G; Thar TT; Barget N; et al. Changes in the serum proteome associated with the development of hepatocellular carcinoma in hepatitis C-related cirrhosis | 0 | 0 |
| 88 | 4 | 117 | 88 2006 EXPERT REVIEW OF MOLECULAR DIAGNOSTICS 6 (2): 179-191 Ginsburg GS; Haga SB Translating genomic biomarkers into clinically useful diagnostics | 0 | 0 |
| 89 | 2 | 17 | 89 2006 GYNECOLOGIC ONCOLOGY 100 (2): 247-253 Kong FB; White CN; Xiao XY; Feng YJ; Xu CJ; et al. Using proteomic approaches to identify new biomarkers for detection and monitoring of ovarian cancer | 0 | 0 |
| 90 | 6 | 158 | 90 2006 JOURNAL OF BIOMEDICAL INFORMATICS 39 (2): 227-248 Shin HJ; Markey MK A machine learning perspective on the development of clinical decision support systems utilizing mass spectra of blood samples | 0 | 0 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 91 | 2 | 32 | 91 2006 JOURNAL OF BIOMOLECULAR SCREENING 11 (1): 90-99 Baumgartner C; Baumgartner D Biomarker discovery, disease classification, and similarity query processing on high-throughput MS/MS data of inborn errors of metabolism | 0 | 0 |
| 92 | 2 | 37 | 92 2006 JOURNAL OF PROTEOME RESEARCH 5 (2): 254-261 Beyer S; Walter Y; Hellmann J; Kramer PJ; Kopp-Schneider A; et al. Comparison of software tools to improve the detection of carcinogen induced changes in the rat liver proteome by analyzing SELDI-TOF-MS spectra | 0 | 0 |
| 93 | 1 | 29 | 93 2006 RESPIROLOGY 11 (1): 41-48 Murphy VE; Johnson RF; Wang YC; Akinsanya K; Gibson PG; et al. Proteomic study of plasma proteins in pregnant women with asthma | 0 | 0 |
| 94 | 2 | 58 | 94 2006 TRANSFUSION MEDICINE AND HEMOTHERAPY 33 (1): 97-105 Wilkins MR How proteomics can assist in the detection and avoidance of adverse drug reactions | 0 | 1 |
Generated by HistCite 2006.02.28